Linda West
CIK: 0001805257
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNTX
Context Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About West Linda
West Linda (SEC CIK 0001805257) files insider reports with the SEC as Director of Context Therapeutics Inc. (CNTX).
Signal8 holds 2 ownership filings by West Linda, all Form 4s, filed between Jun 12, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on West Linda's filings is in PHILADELPHIA, PA.
Recent filings by West Linda
Other insiders filing for Context Therapeutics Inc. (CNTX)
- Pasternak Andy, Director
- Stacey Jennifer Evans, Director
- Smith Karen L., Director
- Walker Luke Nathaniel, Director
- Kantoff Philip W., Director
- Levit Alex C., Chief Legal Officer, Corp. Sec